Literature DB >> 12209534

Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome.

Serge D Steinfeld1, Thierry Appelboom, Christine Delporte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209534     DOI: 10.1002/art.10440

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Authors:  Roland Jonsson; Tom P Gordon; Yrjö T Konttinen
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

3.  Aquaporin-8 expression is reduced in ileum and induced in colon of patients with ulcerative colitis.

Authors:  Alexandra Zahn; Christoph Moehle; Thomas Langmann; Robert Ehehalt; Frank Autschbach; Wolfgang Stremmel; Gerd Schmitz
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

4.  Polysaccharides of Dendrobium officinale inhibit TNF-α-induced apoptosis in A-253 cell line.

Authors:  L Xiang; C W Stephen Sze; T B Ng; Y Tong; P C Shaw; C W Sydney Tang; Y B Kalin Zhang
Journal:  Inflamm Res       Date:  2012-12-25       Impact factor: 4.575

Review 5.  Physiological role of aquaporin 5 in salivary glands.

Authors:  Kazuo Hosoi
Journal:  Pflugers Arch       Date:  2015-11-05       Impact factor: 3.657

Review 6.  What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?

Authors:  Cees G M Kallenberg; Arjan Vissink; Frans G M Kroese; Wayel H Abdulahad; Hendrika Bootsma
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.